MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
108 hedge funds and large institutions have $1.56B invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+27
Holders Change %
+33.33%
% of All Funds
2.48%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.21%
New
54
Increased
29
Reduced
17
Closed
26
Calls
$16.7M
Puts
$7.45M
Net Calls
+$9.21M
Net Calls Change
+$9.52M
Top Buyers
1 |
DM
Deerfield Management
New York
|
+$54.4M |
2 |
BlackRock
New York
|
+$40.3M |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$39.5M |
4 |
BI
BVF Inc
San Francisco,
California
|
+$36.7M |
5 |
PA
Perceptive Advisors
New York
|
+$33.7M |
Top Sellers
1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$33M |
2 |
BC
Broadfin Capital
New York
|
-$20.9M |
3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.5M |
4 |
Millennium Management
New York
|
-$11.7M |
5 |
PC
PointState Capital
New York
|
-$9.16M |